Literature DB >> 31271518

Friend or Foe? Evidence Indicates Endogenous Exosomes Can Deliver Functional gRNA and Cas9 Protein.

Ran Chen1, Hongxin Huang1, Hui Liu1, Jingyuan Xi1, Jing Ning1, Wanjia Zeng1, Congle Shen1, Ting Zhang1, Guangxin Yu1, Qiang Xu1, Xiangmei Chen1, Jie Wang1, Fengmin Lu1.   

Abstract

The clustered regularly interspaced short palindromic repeats (CRISPR)/associated nuclease (Cas) system is an efficient gene editing tool. In this study, it is found that both single guide RNA (gRNA) and Cas9 protein could be exported from the CRISPR/Cas9-expressing cells by endogenous exosomes independently. Further experiments demonstrate that these naturally produced endogenous exosomes could be used as a vehicle to deliver the functional Cas9 and hepatitis B virus (HBV)-specific gRNA to cut HBV DNA transfected in HuH7 cells or human papilloma virus (HPV)-specific gRNA to cut the integrated HPV DNA in HeLa cells, respectively. In conclusion, this study indicates the potential of endogenous exosomes as a safe and effective delivery vehicle of the functional gRNA and Cas9 protein. Meanwhile, the endogenous exosomes-mediated delivery of gene editing activity to adjacent and distant cells or tissues may further complicate the off-target and safety concerns about the CRISPR/Cas9 system.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CRISPR/Cas9; delivery systems; exosomes

Year:  2019        PMID: 31271518     DOI: 10.1002/smll.201902686

Source DB:  PubMed          Journal:  Small        ISSN: 1613-6810            Impact factor:   13.281


  17 in total

1.  Measurement and standardization challenges for extracellular vesicle therapeutic delivery vectors.

Authors:  Bryant C Nelson; Samantha Maragh; Ionita C Ghiran; Jennifer C Jones; Paul C DeRose; Elzafir Elsheikh; Wyatt N Vreeland; Lili Wang
Journal:  Nanomedicine (Lond)       Date:  2020-09-04       Impact factor: 5.307

2.  CRISPR-SCReT (CRISPR-Stop Codon Read Through) method to control Cas9 expression for gene editing.

Authors:  Pouiré Yaméogo; Benjamin L Duchêne; Nathalie Majeau; Jacques P Tremblay
Journal:  Gene Ther       Date:  2021-10-01       Impact factor: 5.250

Review 3.  CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease.

Authors:  Mujeeb Ur Rahman; Muhammad Bilal; Junaid Ali Shah; Ajeet Kaushik; Pierre-Louis Teissedre; Małgorzata Kujawska
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

4.  Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy.

Authors:  Rui Chen; Weilin Yuan; Yongjun Zheng; Xiaolan Zhu; Bing Jin; Tingting Yang; Yuwei Yan; Wanru Xu; Hongjian Chen; Juan Gao; Guoping Li; Priyanka Gokulnath; Gururaja Vulugundam; Jin Li; Junjie Xiao
Journal:  J Nanobiotechnology       Date:  2022-06-27       Impact factor: 9.429

Review 5.  Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing.

Authors:  Li Duan; Kan Ouyang; Xiao Xu; Limei Xu; Caining Wen; Xiaoying Zhou; Zhuan Qin; Zhiyi Xu; Wei Sun; Yujie Liang
Journal:  Front Genet       Date:  2021-05-12       Impact factor: 4.599

Review 6.  CRISPR/Cas9: Principle, Applications, and Delivery through Extracellular Vesicles.

Authors:  Katarzyna Horodecka; Markus Düchler
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

Review 7.  The Role of Exosomes in Pancreatic Cancer.

Authors:  Bin Lan; Siyuan Zeng; Robert Grützmann; Christian Pilarsky
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

Review 8.  Improved Nucleic Acid Therapy with Advanced Nanoscale Biotechnology.

Authors:  Yuhua Weng; Qianqian Huang; Chunhui Li; Yongfeng Yang; Xiaoxia Wang; Jie Yu; Yuanyu Huang; Xing-Jie Liang
Journal:  Mol Ther Nucleic Acids       Date:  2019-12-17       Impact factor: 8.886

Review 9.  Extracellular vesicles as delivery systems at nano-/micro-scale.

Authors:  Peiwen Fu; Jianguo Zhang; Haitao Li; Michael Mak; Wenrong Xu; Zhimin Tao
Journal:  Adv Drug Deliv Rev       Date:  2021-08-03       Impact factor: 15.470

Review 10.  Gene Editing by Extracellular Vesicles.

Authors:  Dmitry Kostyushev; Anastasiya Kostyusheva; Sergey Brezgin; Valery Smirnov; Elena Volchkova; Alexander Lukashev; Vladimir Chulanov
Journal:  Int J Mol Sci       Date:  2020-10-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.